Zai Lab Ltd
Nasdaq: ZLABPharmaceutical Preparations · Entity-resolved by Clous
CIK0001704292
TickerZLAB
ExchangeNasdaq
SIC2834
StateE9
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2025-12-31
$457.18M
+15.0% YoY
Net IncomeFY2025-12-31
-$175.54M
+31.7% YoY
Total AssetsFY2025-12-31
$1.17B
-1.1% YoY
EquityFY2025-12-31
$715.5M
-14.9% YoY
Shares OutstandingFY2025-12-31
88.59M
—
Operating Cash FlowFY2025-12-31
-$150.79M
+29.8% YoY
Short interest & fails
Cost to borrow3.02%450K shares availablehard to borrow
Short-sale volume
FINRA Reg SHO · daily50.0%
short of total volume · 2026-06-18
2026-06-1850.0%
2026-06-1780.0%
2026-06-1658.7%
2026-06-1568.8%
2026-06-1277.0%
Fails-to-deliver
SEC CNS fails · semi-monthly6.1K
shares failed · 2026-05-28
2026-05-286.1K sh$18.69
2026-05-264.02K sh$18.61
2026-05-226 sh$19.10
2026-05-216 sh$18.81
2026-05-19586 sh$18.86
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $212.67M | $266.72M | $397.61M | $457.18M | +15.0% | 100% |
| Net Income | -$443.29M | -$334.62M | -$257.1M | -$175.54M | +31.7% | -38% |
| Total Assets | $1.22B | $1.04B | $1.19B | $1.17B | -1.1% | 256% |
| Equity | $1.05B | $796.12M | $840.9M | $715.5M | -14.9% | 157% |
| Operating Cash Flow | -$367.64M | -$198.18M | -$214.87M | -$150.79M | +29.8% | -33% |
| Shares Outstanding | — | — | — | 88.59M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001704292